forte: impact of gain and amplification of 1q in myeloma
Published 3 years ago • 653 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
0:45
the impact of gain/amp(1q) in patients with myeloma
-
1:52
secondary cytogenetic abnormalities in mm: prognostic value of chromosome 1q gain vs amplification
-
2:10
the temporal evolution of chromosome 1q gain and hyperdiploidy in multiple myeloma
-
2:13
founding precision therapy for 1q-amplified multiple myeloma
-
6:13
phase i study of forimtamig, a gprc5dxcd3 bispecific antibody, in r/r multiple myeloma
-
1:07
double oncogenic hits of 17p13(del) and 1q21(amp) in myeloma
-
4:03
ikema long-term sub-group analysis: isa-kd for 1q21 multiple myeloma
-
4:02
the diagnostic and prognostic value of mass spectrometry in multiple myeloma
-
1:46
forte: mrd by mfc or ngs in myeloma
-
6:27
revealing the transcriptional impact of key genomic drivers in myeloma
-
the ovation-2 study and the novel immunotherapy imnn-001 for ovarian cancer
-
3:13
how to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma
-
3:46
variant allele frequency in patients with sf3b1-mutated mds
-
7:19
what is immunotherapy for multiple myeloma? understanding its role in treatment
-
2:41
identification of myeloma high-risk subclones with single-cell technologies
-
1:47
the potential of early treatment of smm with immunotherapy
-
0:53
using single-cell sequencing to define mechanisms of progression from smm to myeloma
-
2:00
real-world outcomes of autosct for multiple myeloma in the first-line setting
-
3:24
prefibrotic myelofibrosis: considerations for diagnosing and managing this entity